Tests a wearable device for remotely monitoring people with COPD
Explores whether a wearable device can remotely monitor adults with COPD flare-ups.
Key facts
- Who runs it
- University of Strathclyde
- Where
- Glasgow, United KingdomSee the site
- Trial code
- Registry title
- The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 1
- Status
- Enrolling by invitation
- People taking part
- 30 people, planned
- Started
- 24 Jun 2024
- Planned end
- 1 Sept 2025
- Type of study
- Observational
- Treatments tested
- Pneumowave DC
- Record updated
- 10 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a current diagnosis of COPD who can use a smartphone or computer. It tests remote monitoring with a wearable device.
- Age
- 18 years or over
- Sex
- All sexes can join
- Disease stage
- Current diagnosis of COPD. No flare-up (acute exacerbation) of COPD in the 6 weeks before joining.
- Earlier treatment
- No lung surgery in the last 6 months. No high-dose oral steroids (10 mg or more of prednisolone a day) for more than 3 months in a row. No long-term oxygen therapy.
Main reasons for not taking part
- Another lung disease that is the main cause of symptoms (for example asthma, lung cancer, tuberculosis)
- Severe alpha-1-antitrypsin deficiency
- Cancer or another terminal condition with 12 months or less to live, in the investigator's opinion
- Pregnancy
- Already in another research study, or in a clinical trial in the last 3 months
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Any person aged 18 years or over
- Current diagnosis of COPD
- Be willing and able to comply with study procedures and be available for study visits. • Be able to use a 'smartphone or computer'
- Be able to give written consent
- Able to understand written and spoken English
Who cannot take part
- Having undergone lung surgery (e.g. lung volume reduction, lobectomy) within the last 6 months
- Taking high-dose oral corticosteroid medication (equivalent to daily dose of ≥10 mg of prednisolone) for more than 3 consecutive months
- Participation in an interventional clinical study within 3 months of Visit 1 or participation in a study using an investigational medicinal product (IMP) either in the previous 3 months or in the interval from last using the IMP to 5 times its half-life
- On long-term oxygen therapy
- Acute exacerbation of COPD within 6 weeks prior to inclusion
- Known respiratory disorders are other than COPD which, in the opinion of the investigator, is the main contributor to the patient's symptoms (e.g. asthma, lung cancer, sarcoidosis, and other interstitial lung diseases (ILDs), tuberculosis, lung fibrosis, cystic fibrosis, and non-COPD related bronchiectasis)
- Known history of significant systemic and other organ-related diseases, other than COPD, which in the opinion of the investigator, is likely to interfere with the study or impact on subject safety (e.g. severe rheumatoid arthritis and Lupus, kidney, liver, endocrine, psychological disorders)
- Have cancer or other terminal condition which, in the opinion of the investigator, has a mortality of 12 months or less. • Have, in the opinion of the investigator, evidence of alcohol, drug or solvent abuse
- Patients with other significant lung disease, unable to consent, unable to use the technology (e.g. inability to use the data device, or complete the questionnaires), or at the clinician's discretion for other more significant medical/social reasons
- Known allergy to surgical adhesive tape
- Inability to give written informed consent
- Known to be severely alpha-1-antitrypsin deficient (PI, SZ or ZZ)
- Based on their medical record if there is any social violence/substance misuse
- Pregnancy
- Patients already involved in an ongoing research study
Where in United Kingdom
- Oakview Medical Practice in AlexandriaGlasgow, United KingdomEnrolling by invitation
About the trial
What the trial wants to find out
The proposed study will explore whether remote monitoring of a COPD patient can be undertaken using a wearable medical device.
The group in the trial
- Patients with COPD
The study population for this research consists of individuals diagnosed with COPD (Chronic Obstructive Pulmonary Disease) who have a history of exacerbation-induced hospitalization within the one-year period preceding recruitment.
Treatment: Pneumowave DC
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Use of Medical Devices to Monitor COPD Patients Study - An Observational Feasibility Study
- Plain-language title
- Tests a wearable device for remotely monitoring people with COPDGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 April 2025